Correlation Between Kinnevik Investment and Annexin Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kinnevik Investment and Annexin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kinnevik Investment and Annexin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kinnevik Investment AB and Annexin Pharmaceuticals AB, you can compare the effects of market volatilities on Kinnevik Investment and Annexin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kinnevik Investment with a short position of Annexin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kinnevik Investment and Annexin Pharmaceuticals.

Diversification Opportunities for Kinnevik Investment and Annexin Pharmaceuticals

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kinnevik and Annexin is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Kinnevik Investment AB and Annexin Pharmaceuticals AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexin Pharmaceuticals and Kinnevik Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kinnevik Investment AB are associated (or correlated) with Annexin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexin Pharmaceuticals has no effect on the direction of Kinnevik Investment i.e., Kinnevik Investment and Annexin Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kinnevik Investment and Annexin Pharmaceuticals

Assuming the 90 days trading horizon Kinnevik Investment is expected to generate 2.6 times less return on investment than Annexin Pharmaceuticals. But when comparing it to its historical volatility, Kinnevik Investment AB is 2.18 times less risky than Annexin Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Annexin Pharmaceuticals AB is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  50.00  in Annexin Pharmaceuticals AB on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Annexin Pharmaceuticals AB or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Kinnevik Investment AB  vs.  Annexin Pharmaceuticals AB

 Performance 
       Timeline  
Kinnevik Investment 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kinnevik Investment AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Kinnevik Investment is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Annexin Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Annexin Pharmaceuticals AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Annexin Pharmaceuticals is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Kinnevik Investment and Annexin Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kinnevik Investment and Annexin Pharmaceuticals

The main advantage of trading using opposite Kinnevik Investment and Annexin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kinnevik Investment position performs unexpectedly, Annexin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexin Pharmaceuticals will offset losses from the drop in Annexin Pharmaceuticals' long position.
The idea behind Kinnevik Investment AB and Annexin Pharmaceuticals AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals